W.R. Berkley Corp’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

W.R. Berkley Corp’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,254	Closed	-$2.42K	–	358
2026 Q1	$2.42K	Hold	17,254	–	–	﹤0.01%	344
2025 Q4	$4.83K	Hold	17,254	–	–	﹤0.01%	284
2025 Q3	$5K	Sell	17,254 -69,511	-80%	-$18.8K	﹤0.01%	233
2025 Q2	$20K	Hold	86,765	–	–	﹤0.01%	212
2025 Q1	$12.2K	Buy	+86,765	New	+$15.3K	﹤0.01%	148

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

W.R. Berkley Corp's TDACW Position: Q2 2026 in Review

W.R. Berkley Corp sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 17,254 shares — an estimated $2.42K sold.

W.R. Berkley Corp first reported a position in TDACW in Q1 2025 and held it in 5 quarters. The position peaked at $20K in Q2 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

W.R. Berkley Corp reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
W.R. Berkley Corp sold 17,254 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $2.42K.
W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 5 quarters.
W.R. Berkley Corp's Translational Development Acquisition Corp Warrants position peaked at $20K in Q2 2025.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on W.R. Berkley Corp's 13F filing for Q2 2026, filed 14 Aug 2026.